Belgium· BE-AMP-SAM302084-00

Advagraf 0.5 mg

A tacrolimus product containing tacrolimus, registered in Belgium by Astellas Pharma Europe. The same ATC class is registered in 16 of our 19 countries.

ATC L04AD02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAdvagraf 0.5 mgATCL04AD02REGISTER NO.BE-AMP-SAM302084-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Tacrolimus is registered in 16 of 19 countries.

Countries holding a registration under ATC L04AD02 (tacrolimus), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose

Tacrolimus · ATC L04AD02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tacrolimus costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.77 in United States to $15.16 in Switzerland — a ×20 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Tacrolimus · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$15.16
  • IT Italy$8.99
  • ES Spain$6.82
  • US United States$0.77 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Tacrolimus
Manufacturer
Astellas Pharma Europe
Country
Belgium (BE)
ATC code
L04AD02
ATC class
Tacrolimus
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    2657617
    EUR 63.88
  • be_apb
    0789628

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1075 interactions on record for tacrolimus.

Graded by severity as the source publishes them — 238 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tacrolimus · interactions on record

1075 records

  • 238 severe
  • 543 moderate
  • 18 minor
  • 217 info

Most severe, free to view

  • ClotrimazoleA01AB18severe
  • OmeprazoleA02BC01severe
  • LansoprazoleA02BC03severe
  • EsomeprazoleA02BC05severe

59 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tacrolimus in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tacrolimus products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Adport, Dailiport
  • Bulgaria · Програф
  • Cyprus · Prograf, Tacrolimus Accord
  • Czechia · Dailiport, Gecrol
  • Germany · Crilomus, Dailiport
  • Denmark · Adport, Dailiport
  • Estonia · Dailiport, Lebsanan
  • Spain · Adoport, Cellmune
  • Finland · Adport, Adport,
  • France · Adoport, Conferoport
  • United Kingdom (Northern Ireland) · Adoport, Ascezo
  • Greece · Atodrit-Dermo, Eczatope Derm
  • Croatia · Atezyrix, Dermitopic
  • Hungary · Prograf, Tacrolimus Stada
  • Ireland · Prograf, Tacrolimus Accord
  • Iceland · Advagraf, Dailiport
  • Italy · Adoport, Carelimus
  • Liechtenstein · Advagraf, Envarsus
  • Lithuania · Dailiport, Lebsanan
  • Luxembourg · Prograft, Sumilor
  • Latvia · Dailiport, Lebsanan
  • Malta · Prograf
  • Netherlands · Adport, Conferoport
  • Norway · Adport, Advagraf
  • Poland · Cidimus, Dailiport
  • Portugal · Adoport, Dermitopic
  • Romania · Prograf, Tacrolimus Sandoz
  • Sweden · Adport, Adport,
  • Slovenia · Adoport, Dailiport
  • Slovakia · Atezyrix, Dailiport

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dce45019-8837-4a22-b945-2eeafb85d674
GET /v1/drugs/dce45019-8837-4a22-b945-2eeafb85d674?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Prolonged-release capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Advagraf 0.5 mg",
  "name_fr": "Advagraf 0.5 mg",
  "name_nl": "Advagraf 0.5 mg",
  "amp_code": "SAM302084-00",
  "strengths": [
    "0.5000",
    "0.5000"
  ],
  "pack_count": 6,
  "substances": [
    "Tacrolimus",
    "Lactose Monohydrate",
    "Sodium Laurilsulfate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Tacrolimus",
  "authorisation_numbers": [
    "EU/1/07/387/009",
    "EU/1/07/387/014",
    "EU/1/07/387/016",
    "EU/1/07/387/015",
    "EU/1/07/387/002",
    "EU/1/07/387/001"
  ]
}

See everything about tacrolimus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.